Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


11 Items
Title  Creator  Group name  Publishing year 
Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma Faron et al. EquipeMY 2023-10-01
Poorly cohesive cells gastric carcinoma including signet-ring cell cancer: Updated review of definition, classification and therapeutic management Drubay et al. EquipeMY 2022-08-15
Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study André et al. EquipeMY 2022-08-15
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe Kroese et al. EquipeMY 2022-03
The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma Lutz et al. EquipeMY Mar 14, 2019
Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials Ronellenfitsch et al. EquipeMY Dec 2019
Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis Bonnot et al. EquipePM May 14, 2019
The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers Mariette et al. EquipeMY 02 06, 2018
A prospective clinical and biological database for pancreatic adenocarcinoma: the BACAP cohort Canivet et al. EquipeAD 2018-10-16
[FREGAT: French clinico-biological database dedicated to esogastric cancers] Renaud et al. EquipeMY Dec 2017
Definitive chemoradiation for resectable carcinoma of the cervical esophagus: do we need more evidence? Adenis et al. EquipeMY Dec 2017
11 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés